White Paper

Novel Cell Lysis Solution: Scaling Up The Harvest Process While Preserving What Matters

Source: Avantor

By Beth Kroeger-Fahnestock Director, New Product Introduction (BioPharma), Avantor, Inc.

J.T.Baker® Endonuclease

The ecotoxicity of Triton X-100 has clearly demonstrated that biomanufacturers should consider a change in their approach to cell lysis. To ensure patient safety — as well as a portable process outside of Europe — it’s time to find a novel reagent without harmful, endocrine-disrupting properties. This white paper presents study data on key features of 100X concentrated, ready-to-use J.T. Baker® Cell Lysis Solution as a scalable alternative that provides complete cell lysis for viral vector recovery.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online